patterns within CSF and blood. While cell-free microRNAs in the blood exhibit potential in diagnosing

the potential of stromal vascular fraction (SVF) cell therapy as a novel regenerative treatment for ICH. SVF

in the unresolved challenge of traversing the blood-brain barrier (BBB) and blood-tumor barrier (BTB) to deliver

from a weakening of the inner muscular layer of a blood vessel wall. IAs represent the most common

is limited by their bioavailability and blood-brain barrier permeability. Many of them have a significant

of conventional treatments for patients with central nervous system diseases. The blood-brain barrier prevents

and therapeutic targets. Exosomal ncRNAs are small RNA molecules that are secreted by cells and transported

characteristics, critical locations, and the unique obstacles posed by the blood-brain barrier (BBB) and blood

Astrocytes, the most prevalent cells in the central nervous system, significantly contribute